1 report

The insulin market, driven by the increasing prevalence of diabetes, is presently witnessing robust double-digit growth, thus pushing strong demand for insulin delivery devices.

  • Thiazolidinedione
  • China
  • GSK China Inc.
  • Novo Nordisk Pharmaceutical Co., Ltd.
  • Zhejiang Expressway Co., Ltd.